Pharmaniaga inks local manufacturing deal with Sinovac Biotech


A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Airbus backs Sarawak’s aviation ambition, sees potential as regional hub
NWE Resources eyes ACE Market listing
Govt reviewing carbon tax implementation amid geopolitical pressures
Theta Edge inks MoU to explore Hajj tech rollout in Indonesia
Ringgit revisits 3.95 against greenback on US-Iran talks hopes
Muhibbah Engineering wins RM120mil Penang LRT contract
Ocean Fresh receives additional tax assessments
Paos lodges proof of debt amounting to RM16.10mil
M'sia to increase biodiesel blend mandate from B10 to B15, says Economy Minister
AMS Advanced Material IPO oversubscribed 9.03 times

Others Also Read